The European Centre for Disease Prevention and Control (ECDC) recently investigated an outbreak of the Andes strain hantavirus. Fortunately, preliminary genome sequencing indicates the virus remains stable. This means the pathogen is not acting differently from known versions. Therefore, health officials are closely monitoring the situation following a recent deadly event on a cruise ship.

Managing Andes strain hantavirus

The Andes strain is notably the only hantavirus known for human-to-human transmission. Consequently, health agencies recommend a strict 42-day quarantine for exposed individuals. This duration is necessary because the incubation period can last up to six weeks. Furthermore, contact tracing should extend to two days before symptoms appear. This precautionary step helps capture potential transmission during the early contagious phase. Moreover, constant monitoring of high-risk contacts is essential for early detection.

Transmission Risks and Protocols

The illness usually spreads through infected rodents' urine, droppings, or saliva. However, the Andes strain poses a unique threat due to its human-to-human spread. In addition, no vaccines or specific treatments currently exist for this virus. Because of this, supportive care and strict monitoring remain the primary management strategies. Moreover, ECDC director Pamela Rendi-Wagner noted that new cases might still emerge among those currently in quarantine. Clinicians should remain alert for symptoms in patients with recent travel history to affected regions.

Frequently Asked Questions

Q1: How long is the incubation period for the Andes strain hantavirus?

The incubation period is relatively long and can take up to six weeks. This is why a 42-day quarantine period is recommended for high-risk contacts.

Q2: Can the Andes strain hantavirus spread between humans?

Yes, the Andes strain is currently the only hantavirus strain known to pass between humans, making it a significant public health concern.

Q3: Are there any specific vaccines or treatments available?

Currently, there are no specific vaccines or antiviral treatments for hantavirus. Treatment focuses on supportive care and symptom management.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. 'No indication' Andes strain of hantavirus has mutated: EU agency - ETHealthworld


2. European Centre for Disease Prevention and Control (ECDC). (2024). Factsheet about hantavirus.


3. World Health Organization (WHO). (2024). Hantavirus Pulmonary Syndrome (HPS).